Efforts and Challenges paved by India to confront of Corona Virus (COVID-19)


  • Mohammad Gayoor Khan Department of Pharmacology, Daksh Institute of Pharmaceutical Science, Chhatarpur,Madhya Pradesh, 471001-India
  • Umama Yezdani Department of Pharmacy Practice, MRM College of Pharmacy, Hyderabad, Telangana, 501510 – India
  • Arghya Chakravorty School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014 – India
  • Tanvi Shukla Department of Pharmaceutical Chemistry, NIRMA University, Ahmedabad, Gujarat, 382481 – India




Government of India,World Health Organization, Lockdown, Corona, Challenges


The clinical range of Covid-19 is a respiratory route infection that varies from Asymptomatic to various clinical conditions such as respiratory failure to multiple organ dysfunction syndromes (MODS). Government administration officials are ramping up many efforts i.e prevention and containing the spread from escalating to the next level, raising the quarantine stations and increase in the laboratory capacity, strengthening surveillance, contact tracing using artificial intelligence (AI) via technology apps. India is Consequently facing many challenges to tackle the pandemic from shortage of medical supply to the devastation of the educational, transportation, job sectors, and healthcare sector, However, pharmaceutical companies taking center stage in the Covid-19 fight, Other pharmaceutical companies(low scale) in India are following suit during the Covid-19 pandemic and using their capabilities to lighten the burden of coronavirus, WHO recommends social distancing and country-wise lockdown are very essential to tackle the coronavirus, the GOI is scheming on how to get back to normalcy, with an actionable exit plan for the states to confront the coronavirus

Bangladesh Journal of Medical Science Vol.19(0) 2020 p. S 88-S 92


Download data is not yet available.




How to Cite

Khan, M. G., Yezdani, U., Chakravorty, A., & Shukla, T. (2020). Efforts and Challenges paved by India to confront of Corona Virus (COVID-19). Bangladesh Journal of Medical Science, 19, S 88–S 92. https://doi.org/10.3329/bjms.v19i0.48198



Review Article